NO961496L - Treatment of allergic diseases with terfenadine carboxylate - Google Patents
Treatment of allergic diseases with terfenadine carboxylateInfo
- Publication number
- NO961496L NO961496L NO961496A NO961496A NO961496L NO 961496 L NO961496 L NO 961496L NO 961496 A NO961496 A NO 961496A NO 961496 A NO961496 A NO 961496A NO 961496 L NO961496 L NO 961496L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- allergic diseases
- terfenadine carboxylate
- terfenadine
- carboxylate
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse an- går en metode for behandling av en pasient som lider av en allergisk syk- dom, omfattende daglig administrering til angitte pasient av en mengde av terfenadinkarboksylat på fra ca. 10 mg til ca. 50 mg.The present invention relates to a method of treating a patient suffering from an allergic disease, comprising daily administration to the indicated patient of an amount of terfenadine carboxylate of from ca. 10 mg to approx. 50 mg.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13754593A | 1993-10-15 | 1993-10-15 | |
| PCT/US1994/011155 WO1995010278A1 (en) | 1993-10-15 | 1994-09-30 | Treatment of allergic disorders with terfenadine carboxylate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961496D0 NO961496D0 (en) | 1996-04-15 |
| NO961496L true NO961496L (en) | 1996-04-15 |
Family
ID=22477906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961496A NO961496L (en) | 1993-10-15 | 1996-04-15 | Treatment of allergic diseases with terfenadine carboxylate |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0723446A1 (en) |
| JP (1) | JPH09506078A (en) |
| CN (1) | CN1136775A (en) |
| AU (1) | AU7963094A (en) |
| CA (1) | CA2172960A1 (en) |
| IL (1) | IL111236A0 (en) |
| NO (1) | NO961496L (en) |
| ZA (1) | ZA947930B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6168755B2 (en) * | 2011-11-22 | 2017-07-26 | 第一三共ヘルスケア株式会社 | Antihistamine composition |
-
1994
- 1994-09-30 CA CA002172960A patent/CA2172960A1/en not_active Abandoned
- 1994-09-30 JP JP7511873A patent/JPH09506078A/en active Pending
- 1994-09-30 AU AU79630/94A patent/AU7963094A/en not_active Abandoned
- 1994-09-30 EP EP94930547A patent/EP0723446A1/en not_active Withdrawn
- 1994-09-30 CN CN 94193779 patent/CN1136775A/en active Pending
- 1994-10-11 IL IL11123694A patent/IL111236A0/en unknown
- 1994-10-11 ZA ZA947930A patent/ZA947930B/en unknown
-
1996
- 1996-04-15 NO NO961496A patent/NO961496L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2172960A1 (en) | 1995-04-20 |
| ZA947930B (en) | 1995-05-26 |
| NO961496D0 (en) | 1996-04-15 |
| JPH09506078A (en) | 1997-06-17 |
| AU7963094A (en) | 1995-05-04 |
| CN1136775A (en) | 1996-11-27 |
| EP0723446A1 (en) | 1996-07-31 |
| IL111236A0 (en) | 1994-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY137348A (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| DE60216830D1 (en) | Pharmaceutical compositions for the treatment of disorders of the CNS or other diseases | |
| GB9519661D0 (en) | Fatty acid treatment | |
| DE69133516D1 (en) | TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTO ATIGENIGEN | |
| DE69930252D1 (en) | USE OF TETRACYCLINES TO TREAT MEASURES OF MEIBOPLE DRUGS | |
| ATE107508T1 (en) | USE OF NALMEFEN OR NALTREXONE IN THE TREATMENT OF AUTOIMMUNE DISEASES. | |
| UA27911C2 (en) | MEANS FOR TREATMENT OR PREVENTION OF PHYSIOLOGICAL DISORDERS CAUSED BY EXCESS TAKHIKININ | |
| DE69526120D1 (en) | USE OF NEBIVOLOL AS AN ANTI-ATHEROGENIC AGENT | |
| DE69943107D1 (en) | TREATMENT OF AUTOIMMUNE DISEASES | |
| ATE239474T1 (en) | USES OF LEVOBUPIVACAIN | |
| ATE179888T1 (en) | OPHTHALMIC PREPARATION FOR THE TREATMENT OR PREVENTION OF DRY EYE AND DISEASES CAUSED THEREFROM, CONTAINING 12-SULFODEHYDROABIC ACID | |
| DE59508961D1 (en) | USE OF INCENSE TO TREAT ALZHEIMER DISEASE | |
| DE69725879D1 (en) | USE OF p-AMINOPHENOL DERIVATIVES FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| DE69424777D1 (en) | 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS | |
| BR9809678A (en) | Triptolyte derivatives useful in the treatment of autoimmune diseases | |
| DE69500673D1 (en) | Medicines for the therapeutic and prophylactic treatment of diseases caused by hyperplasia of the smooth muscle cells | |
| BG105275A (en) | Tan-1057 derivatives | |
| CA2213794A1 (en) | Preventive or therapeutic drug for alzheimer's disease | |
| ATE180669T1 (en) | USE OF PREGNANDER DERIVATIVES TO TREAT TUMORS | |
| NO961496L (en) | Treatment of allergic diseases with terfenadine carboxylate | |
| DE69621786D1 (en) | AMINOTETRAL IN DERIVATIVE FOR THE TREATMENT OF HEART CIRCULAR DISEASE | |
| AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
| DE69626916D1 (en) | Sertraline used to treat post-myocardial infarction patients | |
| AU7230894A (en) | Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases | |
| HUP0004647A2 (en) | Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |